Chemomab Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Chemomab Therapeutics (CMMB) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Chemomab Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Chemomab Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Chemomab Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $970 | 485 | 2.00 |
| 2024-09-30 | $3.6k | 2.3k | 1.57 |
| 2023-09-30 | $125 | 141 | 0.89 |
| 2023-06-30 | $15 | 12 | 1.33 |
| 2023-03-31 | $652 | 411 | 1.59 |
| 2022-12-31 | $15k | 4.6k | 3.20 |
| 2022-09-30 | $12k | 4.9k | 2.46 |
| 2022-03-31 | $4.0k | 885 | 4.52 |
| 2021-12-31 | $0 | 1.8k | 0.00 |
| 2021-09-30 | $18k | 1.8k | 10.53 |
| 2021-06-30 | $3.0k | 139 | 21.58 |
| 2021-03-31 | $24k | 834 | 28.78 |